Cardiomedex
Cardiomedex is a preclinical CRO, highly specialized in cardiovascular and cardiometabolic diseases in collaboration with its affiliates company Physiogenex, specialized in metabolic diseases (obesity/type 2 diabetes & comorbidities). Cardiomedex provides reliable preclinical studies using integrative predictive models of HFpEF , HFrEF, cardiac hypertrophy & fibrosis, myocardial infarction, cardiomyopathy (takotsubo, genetic..), cardiometabolic diseases, hypertension, cardiotoxicity, etc. and new tailor-made models to fulfil our partners’ needs. Cardiomedex offers ex-vivo (vascular reactivity/isolated heart/cardiomyocytes/mitochondrial function) and in-vivo exploration (echocardiography/telemetry/PVloops/ECG/treadmill/tail cuff) to provide in-depth functional characterization.
